Bristol Myers Squibb has ended the week with an agreement to buy Orbital Therapeutics – a developer of in vivo cell therapies – for $1.5 billion in cash. Cambridge, Massachusetts-based Orbital is ...

Bristol-Myers Squibb has upgraded a long-running alliance with Prothena in Alzheimer’s disease, taking an option on a tau protein-targeting antibody in early-stage clinical development. The deal – ...

Most students make their career plans while in school. They join Under Graduate courses of their choice based on that after Class 12. However, most students consider Post-Graduate (PG) courses in ...

Our program is ranked first in Texas and sixth in the nation by U.S. News & World Report. What puts us among the best? We offer: The diversity of clinical settings in the Texas Medical Center – the ...

Ty Pendlebury is CNET's senior editor for TV and home audio, and author of the daily Insider newsletter. He has rigorously tested, reviewed and written about AV equipment for the company since 2006.